Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: Early graft failure (EGF) is a major risk for death after heart transplantation. We studied the impact of an extra-corporeal membrane oxygenation (ECMO) temporary support on the operative mortality and the mean-term survival after EGF.
Materials And Methods: Between January 2000 and December 2006, 394 patients underwent orthotopic heart transplantation at our institution. EGF was observed in 90 (23%) patients. Fifty-four patients (14%) were treated with ECMO support, eight (2%) with other assisting devices, and 28 (7%) received maximal inotropic drug support only.
Results: The overall mortality was 21% (83 patients). EGF was a major risk for death: 13% (35 patients) without EGF versus 58% (49 patients) with EGF, p<0001. Among patients supported with ECMO, 36 (67%) were weaned from the assisting device and 27 (50%) were discharged from the hospital. Overall survival was 73% at 1 year and 66% at 5 years. Absence of EGF improved long-term survival: 78% at 1 year and 70% at 5 years without EGF versus 37% at 1 year and 35% at 5 years with EGF. Patients treated with ECMO have the same 1-year conditional survival as patients not having suffered EGF: 94% at 3 years.
Conclusions: ECMO support is a reliable therapeutic option in severe EGF after cardiac transplantation; furthermore, patients treated with ECMO have the same 1-year conditional survival as patients not having suffered EGF.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejcts.2009.05.034 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drug-induced regeneration of pancreatic beta cells: An approach to cellular therapeutic targets.
Cell Regen
September 2025
Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.
Diabetes mellitus is a common and serious metabolic disease globally, characterized by increased blood glucose levels. The major pathogenesis is the functional impairment of insulin-producing beta cells in the pancreas and the lack of insulin secretion. Although both type 1 and type 2 diabetes develop through distinct pathological mechanisms, they lead to the destruction and/or dysfunction of beta cells, resulting in inadequate beta cell mass to maintain normal blood glucose levels.
View Article and Find Full Text PDFGenetic determinants of testicular sperm extraction outcomes: insights from a large multicentre study of men with non-obstructive azoospermia.
Hum Reprod Open
August 2025
Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
Study Question: What is the diagnostic yield and the pre-testicular sperm extraction (TESE) prognostic value of a non-obstructive azoospermia (NOA)-specific virtual gene panel?
Summary Answer: The diagnostic yield in our cohort was 6.1%, and by combining our data with published literature, we identified 11 genes compatible with testicular sperm production and 19 genes associated with no sperm retrieval in carriers of pathogenic (P) or likely pathogenic (LP) mutations.
What Is Known Already: Azoospermia, the most severe form of male infertility, affects ∼1% of the male population, with TESE being the primary treatment option.
Epidermal Growth Factor Receptor Activation Stimulates SOX9 Expression in Injured Renal Proximal Tubule Epithelial Cells.
J Am Soc Nephrol
September 2025
Department of Veterans Affairs, Nashville, Tennessee.
Background: In surviving renal proximal tubule cells (RPTCs) following acute kidney injury (AKI), the induction of SOX9 expression plays a crucial role in promoting kidney repair. However, persistent upregulation of SOX9 in RPTCs contributes to the development of chronic kidney disease (CKD). The molecular mechanisms underlying SOX9 induction in response to kidney injury are not completely understood.
View Article and Find Full Text PDFEffect of Nd-YAG Laser Versus Epidermal Growth Factor Injection on Salivary Pain Mediators in Myogenic Temporomandibular Disorders (A Randomized Clinical Trial).
J Oral Pathol Med
September 2025
Department of Medical Biochemistry, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Background: Myogenic temporomandibular disorder (MTMD) is a complex disorder of the masticatory apparatus. Many nonsurgical treatments have been introduced for treating MTMD chronic pain. The aim of this study is to test the effect of Nd-YAG laser versus epidermal growth factor (EGF) on painful chronic MTMD through monitoring pain scores and salivary pain mediators' levels.
View Article and Find Full Text PDFHSP90 inhibition induces oncogenic EGF receptor degradation to suppress cell growth in non-small cell lung cancer.
Eur J Pharmacol
August 2025
The Second Department of Thoracic Medical Oncology, Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. Electronic address:
Resistance to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) patients with epidermal growth factor (EGF) receptor mutations severely limits the efficacy of cancer therapies. Therefore, there is an urgent clinical demand to find novel therapeutic strategies that can produce durable responses for such patients. EGF receptor-L858R is a common activating mutation and T790M/C797S can account for acquired resistance to EGF receptor-TKI like gefitinib.
View Article and Find Full Text PDF